Concepedia

John Kirk

JK

5

Publications

1.3K

Citations

5

H-Index

2006

Active since

Affiliations

University College London(Current)

Amicus Therapeutics (United States)

Emory University

Hôpital du Sacré-Cœur de Montréal

Parkinson's Institute and Clinical Center

John Kirk is an author at University College London specializing in cardiology, medicine, and heart failure.

Top concepts

Publications per year

2006–2016

5

Publications

5

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Derralynn Hughes, Daniel G. Bichet et al. · New England Journal of Medicine · 2016 · 535 citations · Full text

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Derralynn Hughes, Suma P. Shankar, Gere Sunder‐Plassmann et al. · Journal of Medical Genetics · 2016 · 370 citations · Full text

The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat

Elfrida R. Benjamin, Maria Cecilia Della Valle, Xiaoyang Wu et al. · Genetics in Medicine · 2016 · 207 citations · Full text

A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

Peter S. Pang, John G.F. Cleland, John R. Teerlink et al. · European Heart Journal · 2008 · 137 citations · Full text

, , +19

HeartQuest Ventricular Assist Device Magnetically Levitated Centrifugal Blood Pump

G. Bearnson, Gordon B. Jacobs, John Kirk et al. · Artificial Organs · 2006 · 32 citations

, , +13

Rows per page

1–5 of 5